McCormick & Company Incorporated (MKC)

Investment Committee Summary

Investment Thesis

At $56.20 on 25 August 2026, McCormick trades at 18x forward earnings, the multiple the market extends to a defensive staple whose branded flavour franchise holds share and grows earnings at a low-single-digit rate. That is close to fair. Our engine's base case sees the single Packaged Foods segment growing slowly at a group operating margin of 15%, producing a twelve-month target of $49.60. The anchors do not agree with each other, and the disagreement is the point: the discounted-cash-flow value is far lower, because the incremental return on the capacity ramp barely clears the cost of capital, while the peer forward-earnings anchor implies less than the tape pays. Blending them leaves the shares trading rich to a triangulated value of $37.92 (-33% versus spot), and the rating is SELL: buyers are paying a quality multiple for growth the cash-flow arithmetic does not yet reward, with net debt of ~$4.7B on the balance sheet. The single most damaging risk is structural volume loss to GLP-1 appetite suppression and to private-label trade-down, which would break the price-and-mix-offsets-volume assumption the whole base case rests on.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($56.20) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear mechanism is structural, not cyclical. GLP-1 adoption durably suppresses snacking and centre-store consumption while grocers expand private-label spice and seasoning lines that undercut the branded shelf on price. Volume then declines rather than merely softening, and price and mix can no longer offset it without accelerating the very trade-down they exist to prevent. Operating margin compresses well below 15% as fixed manufacturing capacity and the newer capacity ramp deleverage, and the market re-rates a shrinking staple from 18x toward a distressed multiple. Earnings and the rating multiple therefore fall together rather than in sequence, which is what takes the structural target below the 52-week low. With net debt of ~$4.7B already on the balance sheet, a weaker earnings base also pressures the buyback and the wider shareholder-return programme that supports the equity story, so the return floor most staples investors rely on is the first thing to give.

Key Debate

Gross Margin explains 50% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 18.2× consensus forward EPS, vs the house DCF terminal 14.0×, and a peer median 16.6×. The house DCF sits 53% below spot, so the market is pricing in more than the house case — roughly 3.5pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($21.30) to a 'Bull — Margin Recovery / Re-Rate' bull case ($86.10); the probability-weighted blend (PWEV $49.58) is -12% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.6% of revenue; free cash flow net of SBC is $0.69B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — GLP-1 / Private-Label Erosion (24%, $21.30). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Volume / Cost Recession (18%, $40.50). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising.
• Base — Price/Mix Offsets Volume (32%, $55.00). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns.
• Growth — Snacking + Premiumization (18%, $70.50). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Margin Recovery / Re-Rate (8%, $86.10). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $45.50 and 32% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (50% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 14.0x terminal FCF multiple → $26.35. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $38.72; the peer-median forward P/E is 16.6x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 51% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 16.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 17.9× (simple median 16.6×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $44.82–$75.83, centre $58.30 (+4% vs spot); spot sits at the 37th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Margin Recovery / Re-Rate): $86.10.

Company Overview & Business Model

McCormick & Company Incorporated — CONSUMER DEFENSIVE · PACKAGED FOODS. McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.

How it makes money.

Edge. Narrow moat — McCormick's edge is brand share, shelf-space incumbency and flavour-formulation IP in Flavor Solutions - real but eroding at the margin; if private-label spice and GLP-1-driven volume decline compress the branded premium, the ~16x forward multiple is fair-to-rich and the terminal multiple should sit near the staples group, not above it.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-11-30 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 122% — cash-backed.

Competitive Moat

Moat sources:

• Leading branded share in US spices/seasonings with shelf-space incumbency
• Flavor Solutions B2B formulation IP and customer switching costs (reformulation risk)
• Scale in flavour R&D and global sourcing/distribution
• Eroding pricing umbrella as grocers expand private-label spice lines

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.54 vs analyst floor +0.00 → delta +0.54 (n=25 mgmt / 24 Q&A; 78th pctile across the S&P book, z +0.9).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 911 articles): avg ticker sentiment +0.12 (bullish 16% / bearish 3%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-01 (~38d) — FY2026 (Nov year-end) volume-inflection print / FY2027 guide (authored)
• 2026-10-06 (~43d) — Quarterly earnings — est. EPS $0.75 (AV EARNINGS_CALENDAR)
• 2026-11-15 (~83d) — Cost-savings program (CCI) run-rate update (authored)
• 2027-01-15 (~144d) — Flavor Solutions new-customer / reformulation win cadence (authored)

Forecast Track Record

• EPS surprise: beat 75% of the last 8 quarters; average surprise +7.1%.
• Prior-forecast backtest (12 snapshots, 2026-06-26→2026-08-20): directional hit-rate 0%; mean predicted -3.8% vs realised +9.0%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

7 catalysts in the next 90 days (of 16 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic volume growth (consolidated) < -0.02 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Adjusted operating margin < 0.14 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Consumer segment organic sales growth < 0.0 (2 consecutive prints). A branded-consumer franchise going ex-growth removes the premiumisation offset and points at the structural path rather than a cyclical dip.
• Gross margin < 0.37 (2 consecutive prints). Gross margin below the high-30s for two quarters shows commodity, packaging and freight costs outrunning pricing, the mechanism behind margin compression.
• Full-year adjusted EPS guidance < 2.9 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
• Net leverage (net debt / EBITDA) > 3.5 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $56.20; 52-week range $44.82–$75.83; engine rating SELL; house target $49.60 (-12%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $37.92 (-33% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

50.1/100 (confidence band 39.2–61.0), 19th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 50.9 → 50.9 → 51.2 → 50.2 → 50.2 → 51.0 → 50.4 → 50.4.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $49.58.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.11, vs QQQ -0.02 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Protective Put. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• bearish/holder — hedge the position; a collar finances the put by capping upside
• Direction bearish from the overlay conviction/rating (read-only input).
• IV/RV at the 47th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 75th percentile of its own month-end history (decile 8). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +8.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
• No live-chain Protective Put was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.

IV term structure (contango, slope +8.8pp): 25-DTE 28% · 116-DTE 32% · 389-DTE 37%

No live-chain Protective Put was priced for this name — shown as the indicated approach; size against a fresh chain.

Alternatives: Collar, Put Debit Spread. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

research rating is SELL-tier — the model carries no long position.

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the SELL equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 27.8% (moderate regime) · expected move ±5.9% (2026-09-18) · put/call OI 0.53 · ATM Δ 0.65 / Θ -0.03 / ν 0.06 · next earnings 2026-10-06. Direction: NEUTRAL (implied return -32.5% to triangulated fair value $37.92).

Covered Call (if held) (Income / neutral) — Short 60 C · 2026-09-18 · premium $0.4 · yield 0.7% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Protective Collar (if held) (Hedge) — Long 50 P / Short 60 C · 2027-03-19 · net $1.47 · floor -11.0% · cap +7.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = SELL because:

• Probability-weighted scenario value implies -12% vs spot
• Monte Carlo median implies -19% vs spot
• DCF fair value implies -53% vs spot — but this is terminal-value sensitive (exit-multiple $26.35 vs Gordon $36.82, 40% apart), so it carries less weight
• Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -62% vs spot
• Net: the valuation anchor itself sits 32.5% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $3B + PV(terminal) $9B = EV $12B; − net debt $4.7B → equity $7B ÷ diluted shares $0.27B = $26.35/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $36.82/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 7% vs WACC 8.0% → below WACC — the incremental build is value-dilutive.

Peer set

Implied prices at the peer medians: EV/Rev → $38.72 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (18.0); Revenue CAGR ±3pp (12.0); Terminal × ±15% (9.0); Capex intensity ±15% (5.0); WACC ±1pp (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 8.0%, terminal multiple 14×, FY+5 revenue $8B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.